Lexicon Pharmaceuticals LXRX Excess tax benefits associated with employee equity plans (in percent)
Excess tax benefits associated with employee equity plans (in percent) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent.
The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's excess tax benefits associated with employee equity plans (in percent).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's excess tax benefits associated with employee equity plans (in percent)?
- Lexicon Pharmaceuticals (LXRX) reported excess tax benefits associated with employee equity plans (in percent) of -4.9% in Q4 2025.
- What does excess tax benefits associated with employee equity plans (in percent) mean?
- The percentage impact on the effective tax rate resulting from excess tax benefits associated with employee equity-based compensation. This metric highlights how equity incentive programs influence the company's overall tax efficiency.